EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows

Snježana Kaštelan iD, Antonela Gverović Antunica iD, Suzana Konjevoda iD, Zora Tomić iD, Ana Sarić, Marjan Kulaš iD, Lorena Kulaš, Emina Kujundžić Begović iD, Samir Čanović, Petra Kovačević, Mira Ivanković

Biomolecules · 16.03.2026 · 16 (3) · 445

DOI: 10.3390/biom16030445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.03.2026. Verfasst von Snježana Kaštelan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Clinical Hospital Dubrava, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Mitochondria, Retinal Degeneration, Retina. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial reactive oxygen species (mtROS) play a dual role in retinal physiology, acting as essential redox signalling mediators under homeostatic conditions but driving oxidative damage and neurodegeneration once regulatory thresholds are exceeded. Owing to the exceptionally high energetic demands of retinal neurons and supporting cells, even subtle perturbations in mitochondrial redox balance can precipitate progressive retinal dysfunction. Increasing evidence indicates that retinal neurodegenerative diseases, including glaucoma, diabetic retinopathy (DR), age-related macular degeneration (AMD), and inherited optic neuropathies, are characterised not by uniform oxidative stress, but by disease- and stage-specific mtROS signatures shaped by mitochondrial quality control capacity. This review synthesises current insights into the sources, regulation, and signalling functions of mtROS in the retina, with particular emphasis on threshold-dependent redox transitions, reverse electron transport, and the progressive failure of mitochondrial quality control mechanisms, including mitophagy, mitochondrial dynamics, and redox-responsive transcriptional networks. The limitations of non-selective antioxidant strategies are critically examined, highlighting why indiscriminate ROS suppression has yielded limited clinical benefit. In contrast, emerging therapeutic approaches aimed at recalibrating mitochondrial redox homeostasis, rather than abolishing physiological signalling, are discussed in the context of disease stage, metabolic state, and mitochondrial competence. By integrating redox biology with mitochondrial quality control and precision medicine concepts, this review proposes a unifying framework in which retinal neurodegeneration is governed by regulated mtROS signalling and the progressive exhaustion of mitochondrial resilience. This model defines critical therapeutic windows for mitochondria-targeted intervention and provides a framework for biomarker-guided patient stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesMitochondriaRetinal DegenerationRetinaNeurodegenerative DiseasesHumansAnimalsOxidative StressOxidation-ReductionSignal Transduction

Stichwörter der Autor:innen

mitochondria-targeted interventionmitochondrial quality controlmitochondrial reactive oxygen species (mtROS)mitophagyprecision medicineredox signallingretinal ganglion cellsretinal neurodegenerationreverse electron transport

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Ophthalmology, Clinical Hospital Dubrava, 10000 Zagreb, Croatia.
  • Fundamentals of Medical Skills, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
  • Department of Ophthalmology, Dubrovnik General Hospital, 20000 Dubrovnik, Croatia.
  • Department of Ophthalmology, Zadar General Hospital, 23000 Zadar, Croatia.
  • Department of Health Studies, University of Zadar, 23000 Zadar, Croatia.
  • Health Centre of the Croatian, Department of Internal Affairs, 10000 Zagreb, Croatia.

ORCID-Profile: Snježana Kaštelan, Antonela Gverović Antunica, Suzana Konjevoda, Zora Tomić, Marjan Kulaš, Emina Kujundžić Begović

Zitieren

APA

Kaštelan, S., Antunica, A. G., Konjevoda, S., Tomić, Z., Sarić, A., Kulaš, M., Kulaš, L., Begović, E. K., Čanović, S., Kovačević, P., & Ivanković, M. (2026). Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows. Biomolecules, 16(3), 445. https://doi.org/10.3390/biom16030445

Vancouver

Kaštelan S, Antunica AG, Konjevoda S, Tomić Z, Sarić A, Kulaš M, et al. Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows. Biomolecules. 2026;16(3):445. doi:10.3390/biom16030445

BibTeX
@article{Katelan2026,
  author = {Kaštelan, Snježana and Antunica, Antonela Gverović and Konjevoda, Suzana and Tomić, Zora and Sarić, Ana and Kulaš, Marjan and Kulaš, Lorena and Begović, Emina Kujundžić and Čanović, Samir and Kovačević, Petra and Ivanković, Mira},
  title = {Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {445},
  doi = {10.3390/biom16030445}
}
Kostenlos starten →